| __timestamp | BioMarin Pharmaceutical Inc. | Bristol-Myers Squibb Company |
|---|---|---|
| Wednesday, January 1, 2014 | 751040000 | 15879000000 |
| Thursday, January 1, 2015 | 889895000 | 16560000000 |
| Friday, January 1, 2016 | 1116854000 | 19427000000 |
| Sunday, January 1, 2017 | 1313646000 | 20776000000 |
| Monday, January 1, 2018 | 1491212000 | 22561000000 |
| Tuesday, January 1, 2019 | 1704048000 | 26145000000 |
| Wednesday, January 1, 2020 | 1860455000 | 42518000000 |
| Friday, January 1, 2021 | 1846275000 | 46385000000 |
| Saturday, January 1, 2022 | 2096039000 | 46159000000 |
| Sunday, January 1, 2023 | 2419226000 | 45006000000 |
| Monday, January 1, 2024 | 2853915000 | 48300000000 |
Cracking the code
In the competitive landscape of the pharmaceutical industry, revenue growth is a key indicator of success. Over the past decade, Bristol-Myers Squibb Company has consistently outpaced BioMarin Pharmaceutical Inc. in annual revenue. From 2014 to 2023, Bristol-Myers Squibb's revenue surged by approximately 183%, peaking at $46 billion in 2021. In contrast, BioMarin's revenue grew by about 222%, reaching $2.4 billion in 2023. Despite BioMarin's impressive growth rate, Bristol-Myers Squibb's revenue remains nearly 20 times larger, underscoring its dominance in the sector. This disparity highlights the scale and market reach of Bristol-Myers Squibb, a pharmaceutical giant with a diverse portfolio. As the industry evolves, both companies continue to innovate, but Bristol-Myers Squibb's financial prowess sets a high bar for competitors.
Novartis AG or Bristol-Myers Squibb Company: Who Leads in Yearly Revenue?
Pfizer Inc. vs BioMarin Pharmaceutical Inc.: Annual Revenue Growth Compared
Revenue Insights: Amgen Inc. and BioMarin Pharmaceutical Inc. Performance Compared
Comparing Revenue Performance: Sanofi or BioMarin Pharmaceutical Inc.?
Annual Revenue Comparison: Bristol-Myers Squibb Company vs Corcept Therapeutics Incorporated
Bristol-Myers Squibb Company vs Ionis Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Revenue Showdown: Bristol-Myers Squibb Company vs MorphoSys AG
Who Generates More Revenue? Bristol-Myers Squibb Company or Merus N.V.
Comparing Revenue Performance: BioMarin Pharmaceutical Inc. or Lantheus Holdings, Inc.?
Annual Revenue Comparison: BioMarin Pharmaceutical Inc. vs HUTCHMED (China) Limited
BioMarin Pharmaceutical Inc. vs ImmunityBio, Inc.: Annual Revenue Growth Compared
Revenue Insights: BioMarin Pharmaceutical Inc. and Celldex Therapeutics, Inc. Performance Compared